First Citizens Bank & Trust’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,436
Closed -$243K 653
2025
Q3
$243K Sell
24,436
-19,197
-44% -$200K 0.01% 582
2025
Q2
$433K Buy
43,633
+28,666
+192% +$302K 0.01% 465
2025
Q1
$194K Buy
+14,967
New +$198K ﹤0.01% 498

Other funds holding DVAX

First Citizens Bank & Trust's DVAX Position: Q4 2025 in Review

First Citizens Bank & Trust sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 24,436 shares — an estimated $243K sold.

First Citizens Bank & Trust first reported a position in DVAX in Q1 2025 and held it in 3 quarters. The position peaked at $433K in Q2 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • First Citizens Bank & Trust reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • First Citizens Bank & Trust sold 24,436 Dynavax Technologies shares in Q4 2025, an estimated $243K.
  • First Citizens Bank & Trust first reported a position in Dynavax Technologies in Q1 2025 and held it in 3 quarters.
  • First Citizens Bank & Trust's Dynavax Technologies position peaked at $433K in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on First Citizens Bank & Trust's 13F filing for Q4 2025, filed 18 Feb 2026.